Adicet Bio (ACET) Current Leases (2020 - 2026)

Adicet Bio's Current Leases history runs 7 years deep, the most recent figure standing at $2.7 million for Q1 2026.

• In Q1 2026, Current Leases fell 7.88% year-over-year to $2.7 million; the TTM figure through Mar 2026 stood at $2.7 million (down 7.88% YoY), while the FY2025 annual figure was $2.8 million, changed N/A from the prior year.
• Current Leases for Q1 2026 stood at $2.7 million, down from $2.8 million in the prior quarter.
• The five-year high for Current Leases was $3.4 million in Q2 2024, with the low at $340000.0 in Q3 2025.
• The 5-year median for Current Leases is $3.0 million (2023), against an average of $2.7 million.
• The sharpest annual moves came in 2022 and 2025: Current Leases soared 238.34% in 2022, then plunged 89.63% in 2025.
• Adicet Bio's Current Leases stood at $2.5 million in 2022, then climbed by 29.25% to $3.2 million in 2023, then advanced by 1.77% to $3.3 million in 2024, then retreated by 13.45% to $2.8 million in 2025, then slipped by 3.14% to $2.7 million in 2026.
• Business Quant data shows ACET's Current Leases at $2.7 million in Q1 2026, $2.8 million in Q4 2025, and $340000.0 in Q3 2025.